FDCA

Scholar proposes reforms to address deficiencies in FDA’s premarket review powers.

Scholar urges lawmakers to hold multi-level marketing companies liable for misleading claims made by salespeople.

Scholar calls on FDA to prioritize public health by reforming medical device regulation.

Lawyer proposes a new legal framework for reviewing FDA’s refusal to regulate lethal injection drugs.

Scholars reflect on the need for stronger regulatory oversight of cosmetics in the United States.

Scholars examine the regulation of electronic cigarettes and their impact on public health.

FDA should take steps to strengthen the regenerative medicine industry.

Edible insects may become essential in the wake of the COVID-19 crisis, but FDA regulation is lacking.

FDA clarifies its generic drug approval process in an effort to encourage market competition.

The most surprising regulatory dimension of the coronavirus crisis may center on the lifting of rules.

The federal government seeks authority over stem cell treatments but risks thwarting medical advancement.

In the face of a massive viral outbreak, a federal regulator issues unprecedented guidance on validating COVID-19 testing.